healthcare
(122)
Johnson & Johnson left the medicine cabinet.
The name still evokes baby shampoo. The business now runs on cancer medicines, heart pumps and surgical technology. Its reinvention reveals the expensive work of turning scientific progress into everyday care.
Tenet Healthcare thinks outside the hospital
A hospital company found a different engine for growth: surgery centers where patients can go home the same day. The economics explain the attraction; the partnerships explain the machinery.
Connextions put a human in the loop.
Health insurance had a translation problem. Connextions paired trained agents with its own software, building a business that TeleTech bought for $80 million.
Buffalo Medical Group and the art of the handoff
Four doctors brought a wartime lesson home to Buffalo: medicine works better as a team. Eight decades later, the hard part is still getting the handoff right.
Hireology puts hiring on the clock
A great candidate can disappear while a manager clears their inbox. Hireology turns that everyday delay into a problem a business can see, measure and fix.
Grupo Sabin learned to care at scale
Two biochemists built a laboratory in Brasília. A costly mistake, a patient approach to expansion, and R$90 million in automation explain how it became a national health business.
Decisions makes the rules. You can change them.
Business rules have a habit of hiding in code, spreadsheets and somebody’s inbox. Decisions puts them on a visual canvas - and, after merging with ProcessMaker, wants to govern the AI agents joining the queue.
SingleCare and the price you were never meant to compare
A free prescription coupon can sometimes beat an insurance copay. SingleCare has built a business around persuading Americans to ask one more question at the pharmacy counter.
Mphasis Silverline and the expensive art of making Salesforce useful
A studio booking, a mobile appointment, a commercial loan: Mphasis Silverline works where Salesforce meets the untidy business of getting things done. Its calendar app offers a surprisingly clear view of the whole enterprise.
Gilmartin Group and the business of being believed
A healthcare breakthrough needs an investor who understands it. Gilmartin Group works on the awkward space between a company’s evidence, its promises, and the people writing the checks.
Global HealthX wants your startup to survive the hospital
A surgeon’s venture studio is tackling the awkward stretch between a promising healthcare product and a hospital that will actually use it. Its India market programme even makes room for a useful answer: no.
Choice Medical Group brings care closer to home
In California’s High Desert, Choice Medical Group connects a network of 300-plus providers with urgent care, nursing support, and a senior club where the paintbrushes matter, too.
Loka stopped chasing a hit. It started building yours.
The Silicon Valley consultancy found its business in other people’s hard problems. Today, its work runs from investment proposals to drug discovery, with an unusually concrete test for AI: does it make it into use?
Conquest Research Found Drug Development's Most Human Bottleneck: The Patients
Drug makers can design a promising study and still lose years waiting for the right people to enroll. Conquest Research built a local, patient-facing machine to make that slow middle move faster - then took it across three states.
The Buyers' Club Keeping Cancer Clinics Independent
How a group-buying network built by former pharma executives quietly became the largest independent community-oncology network in the country - and why staying small and independent is the whole point.
The Bank That Would Rather Have One Client Than a Hundred
Founded by dealmakers who left Morgan Stanley and TPG, Incentrum Group built a merchant bank around a contrarian idea - take fewer clients, own the advice, and put your own money where your counsel is.
The Fund That Only Swings at the Ones It Can Hit
A Boston venture firm borrowed its name from the last man to hit .400 in baseball - and built a discipline of only swinging at cybersecurity, healthcare, and data + AI deals where it holds an unfair advantage.
The Firm That Bets on the Toolmakers, Not the Cure
For nearly four decades, Ampersand Capital Partners has skipped the lottery of drug discovery and quietly backed the companies that make the drug discovery possible. In May 2026 it closed a $1.5 billion fund in a single day.
The Firm That Funds the Things That Probably Won't Work
Vinod Khosla left a top-tier partnership to write checks nobody else would. Two decades and one $50 million OpenAI bet later, the willingness to be wrong looks like a strategy.
The Orlando Fund Betting That the Next Big Startup Won't Come From Silicon Valley
A venture firm in Orlando is wagering that the founders worth backing are the ones nobody in Silicon Valley has a flight booked to meet - and it wants to be the first money in.
RRE Ventures Has Been Playing the Long Game Since 1994 - and It Shows
The New York firm wrote early checks into Palantir, Datadog and Venmo, then stayed in the boardroom for the parts that actually get hard.
Brookdale Is Building a Small City for Every Stage of Aging
The country's largest senior-living operator is trying to make one hard transition feel less like a handoff and more like a life that can keep unfolding - with care, community and clinical coordination under one roof.
The Wheelchair Isn't the Product. The Fit Is.
Numotion builds roughly half of America's complex wheelchairs one measurement at a time - then spends the next decade keeping them rolling.
The 176-Year-Old Startup That Sells Science by the Milligram
It began as a candy-flavored worm medicine in a Brooklyn brick house. Today Pfizer is racing to replace its Covid windfall with cancer drugs and weight-loss pills before the patents run out.
The Hospital Network Betting That Great Care Can Stay Close to Home
Lifepoint Health has grown from 23 community hospitals into a coast-to-coast care network. Its wager is simple to describe and difficult to execute: give smaller markets the infrastructure of a national system without asking patients to leave home for care.
Magellan Health
It started as a chain of psychiatric hospitals in Georgia. Fifty-plus years later, Magellan Health decides how millions of Americans get their mental health care approved - and after a $2.2 billion round trip through Centene, it is about to be on its own again.
Johnson & Johnson
It stopped making the Band-Aid. What is left is a $94-billion bet that the future of Johnson & Johnson is written on a prescription pad and a robotic arm.
Virtusa
The 1996 startup that bet enterprises would move their software off-premise now runs on an 'Engineering First' creed - and is wiring generative AI into banks, insurers and hospitals that can't afford to guess.
Humana
How a 1961 nursing-home bet in Louisville became a Medicare Advantage powerhouse - and why Humana is now buying the clinic, the pharmacy and the house call instead of just the insurance card.
Sun Pharma
Sun Pharma became India’s largest drugmaker by mastering generics. Now a portfolio of skin, eye and cancer medicines - and an audacious pending Organon deal - is changing what the company wants to be.